BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30357762)

  • 21. Physical activity and its related factors in Japanese people with haemophilia.
    Goto M; Haga N; Takedani H
    Haemophilia; 2019 Jul; 25(4):e267-e273. PubMed ID: 31132810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fitness and quality of life in children with haemophilia.
    Broderick CR; Herbert RD; Latimer J; Curtin JA
    Haemophilia; 2010 Jan; 16(1):118-23. PubMed ID: 19709313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in coagulation parameters with exercise in patients with classic hemophilia.
    Koch B; Luban NL; Galioto FM; Rick ME; Goldstein D; Kelleher JF
    Am J Hematol; 1984 Apr; 16(3):227-33. PubMed ID: 6424436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilia and exercise.
    Souza JC; Simoes HG; Campbell CS; Pontes FL; Boullosa DA; Prestes J
    Int J Sports Med; 2012 Feb; 33(2):83-8. PubMed ID: 22095329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of danazol on coagulation parameters and bleeding in hemophilia.
    Garewal HS; Corrigan JJ; Durie BG; Jeter MA; Damiano ML
    JAMA; 1985 Feb; 253(8):1154-6. PubMed ID: 3968845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets and hemophilia: A review of the literature.
    Riedl J; Ay C; Pabinger I
    Thromb Res; 2017 Jul; 155():131-139. PubMed ID: 28550758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemophilia in Iran.
    Dorgalaleh A; Dadashizadeh G; Bamedi T
    Hematology; 2016 Jun; 21(5):300-10. PubMed ID: 26914731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding symptoms in carriers of hemophilia A and B.
    Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ
    Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
    Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clustering of Thrombin Generation Test Data Using a Reduced Mathematical Model of Blood Coagulation.
    Ratto N; Tokarev A; Chelle P; Tardy-Poncet B; Volpert V
    Acta Biotheor; 2020 Mar; 68(1):21-43. PubMed ID: 31853681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and survival of cancers among 1,054 hemophilia patients: A nationwide and 14-year cohort study.
    Huang YC; Tsan YT; Chan WC; Wang JD; Chu WM; Fu YC; Tong KM; Lin CH; Chang ST; Hwang WL
    Am J Hematol; 2015 Apr; 90(4):E55-9. PubMed ID: 25639564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of exercise in people with haemophilia: An umbrella review of systematic reviews and meta-analyses.
    Siqueira TC; Dominski FH; Andrade A
    Haemophilia; 2019 Nov; 25(6):928-937. PubMed ID: 31667968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovations in coagulation: improved options for treatment of hemophilia A and B.
    Pabinger-Fasching I; Pipe S
    Thromb Res; 2013 Mar; 131 Suppl 2():S1. PubMed ID: 23537720
    [No Abstract]   [Full Text] [Related]  

  • 34. Modelling the effect of amplification pathway factors on thrombin generation: A comparison of hemophilias.
    Bungay SD
    Transfus Apher Sci; 2008 Feb; 38(1):41-7. PubMed ID: 18294917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant?
    Dargaud Y; Bordet JC; Francillon S; Négrier C
    Thromb Haemost; 2007 Apr; 97(4):675-6. PubMed ID: 17393033
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of moderate intensity exercise on haemostatic capacity in adults with haemophilia A and B: pilot study.
    Sholzberg M; Floros G; Schneiderman JE; Kahr WH; Rand M; Pluthero F; Hossain T; Mahamad S; Nisenbaum R; Zhang C; O'Neill NE; Teitel J; Carcao M
    Haemophilia; 2017 Mar; 23(2):e162-e165. PubMed ID: 28111839
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors that influence the bleeding phenotype in severe hemophilic patients.
    Rendo P; Shafer F; Korth-Bradley JM; Sivamurthy K; Korin J
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):683-90. PubMed ID: 24056291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prothrombotic State Induced by Middle-Distance Endurance Exercise in Middle-Aged Athletes.
    Lippi G; Salvagno GL; Tarperi C; Gelati M; Montagnana M; Danese E; Festa L; Sanchis-Gomar F; Favaloro EJ; Schena F
    Semin Thromb Hemost; 2018 Nov; 44(8):747-755. PubMed ID: 30119138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The socioeconomic burden of patients affected by hemophilia with inhibitors.
    D'Angiolella LS; Cortesi PA; Rocino A; Coppola A; Hassan HJ; Giampaolo A; Solimeno LP; Lafranconi A; Micale M; Mangano S; Crotti G; Pagliarin F; Cesana G; Mantovani LG
    Eur J Haematol; 2018 Oct; 101(4):435-456. PubMed ID: 29889317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.